Clinical Trials Browser

Kidney Neoplasms

NCT02087852 2026-04-09

Kidney Cancer DNA Registry

Recruiting

750 enrolled

Genitourinary

Kidney Neoplasms

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

Recruiting

125 enrolled

Genitourinary

Prostatic Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

Recruiting

324 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06960798 2026-03-02

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Recruiting

150 enrolled

Genitourinary

Prostatic Neoplasms

NCT06674811 2026-01-26

BRICCS

Recruiting

40 enrolled

CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT06147414 2026-01-15

DANNIgene

Recruiting

550 enrolled

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

Clinical Trials

BIOSUNTOX

Kidney Cancer DNA Registry

Mechanisms of Resistance to PSMA Radioligand Therapy

ELEPHAS-04

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

BRICCS

DANNIgene

Cancer DNA Detection in Blood and Urine

CHEMOPROST

Early Ageing During Therapy in AYA Cancer Patients

ITHORinVHL

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

FUTURE

Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

The Effect of IBD Flares on Serum PSA

LUTRAC

PROMECI

SoMuKT

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

PROMIC

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

CHARTER

IRSTB030

ANGIOCOR

CINECI

Bone Marrow Suppression and Recovery During Radionuclide Treatment

PROTECT

ADOPT

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes

NEUROTAX

PROMPT

Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

Circulating Tumor Cells in Prostate Cancer Patients

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels

Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT

Genetic Biomarker Discovery for Metastatic Prostate Cancer

VPCA-B+PIV

NISar

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

CTC

BIOMETHS

Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer

A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer

CirCanCell